BIOEQUIVALENCE OF 2 FORMULATIONS OF PIROXICAM

被引：0
|
作者：
MICHOTTE, Y [1 ]
VANKLAVEREN, HP [1 ]
DETAEVERNIER, MR [1 ]
GUSDORF, CF [1 ]
VANHAELST, L [1 ]
机构：
[1] PHARBITA BV,ZAANDAM,NETHERLANDS
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1991年 / 41-1卷 / 03期
关键词：
ANTIINFLAMMATORIES; NONSTEROIDAL; CAS-36322-90-4; PIROXICAM; BIOEQUIVALENCE; CLINICAL PHARMACOKINETICS;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two separate studies were performed with 12 volunteers in order to demonstrate the bioequivalence of 2 piroxicam (CAS 36322-90-4) tablet and 2 piroxicam suppository formulations after single dose administration. A validated reversed-phase HPLC method with UV-detection is described. Bioequivalence assessment was done by using the posterior probability of a mean ratio between 0.8 and 1.2, and by using the Two One-Sided Tests Procedure (i.e. the 90% confidence interval). The probability approach and the confidence interval approach were compared.
引用
收藏
页码：244 / 246
页数：3
相关论文
共 50 条
  • [31] PHARMACOKINETICS AND BIOEQUIVALENCE OF DIFFERENT FORMULATIONS OF PIRENZEPINE
    VERGIN, H
    MASCHER, H
    STROBEL, K
    NITSCHE, V
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (09): : 1409 - 1412
  • [32] A bioequivalence study of two formulations of cefaclor
    KitzesCohen, R
    Farin, D
    Marckovich, J
    Wasserman, A
    Gozlan, I
    Iaor, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (06): : 352 - 360
  • [33] Bioequivalence of different prednisolone tablet formulations
    Luippold, G
    Benöhr, P
    Schneider, S
    Marto, M
    Mühlbauer, B
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (08): : 638 - 642
  • [34] Bioequivalence of ivermectin formulations in pigs and cattle
    Lifschitz, A
    Pis, A
    Alvarez, L
    Virkel, G
    Sanchez, S
    Sallovitz, J
    Kujanek, R
    Lanusse, C
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1999, 22 (01) : 27 - 34
  • [35] Bioequivalence of two oral ciprofloxacin formulations
    Morera, M
    Cortés, J
    Ramos, I
    Moncada, J
    Fonseca, L
    CLINICAL DRUG INVESTIGATION, 2001, 21 (02) : 137 - 145
  • [36] Bioequivalence of Two Oral Ciprofloxacin Formulations
    Maritza Morera
    Jaime Cortés
    Irina Ramos
    José Moncada
    Lidieth Fonseca
    Clinical Drug Investigation, 2001, 21 : 137 - 145
  • [37] Bioequivalence between two metronidazole formulations
    Alves, Antonio J.
    Aquino, Thiago M.
    Neto, Jose L. C.
    Filho, Samuel D. S.
    Junor, Honorio J.
    Gaspar, Felipe L.
    Luna, Marco C. M. M.
    Alves, Carlos. J.
    Alves, Anselmo Q.
    Oliveira, Claudia F.
    Goes, Alexandre J. S.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2007, 26 (02): : 266 - 269
  • [38] Bioequivalence study of two metformin formulations
    Al Hawari, Samar
    AlGaai, Eman
    Yusuf, Ahmed
    Abdelgaleel, Abdelraheem
    Hammami, Muhammad M.
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (04): : 192 - 195
  • [39] ESTABLISHING BIOAVAILABILITY AND BIOEQUIVALENCE OF DIAZEPAM FORMULATIONS
    CABANA, B
    PURICH, E
    DOLUISIO, JT
    INTEGRATIVE PSYCHIATRY, 1985, 3 (03): : S79 - S83
  • [40] Bioequivalence of two lamivudine tablet formulations
    Santos-Magalhaes, NS
    Pontes, A
    Cavalcante, RM
    Costa, RMR
    Rangel, FA
    Guimaraes, MIV
    de Carvalho, JNL
    de Souza, SDF
    de Oliveira, HM
    Esteves, ILC
    Ramalho, MS
    Vieira, SLA
    Alves, AJ
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (04): : 310 - 314
12345